Scientific programme
EPA leadership and congress organisers are working together to build an exciting congress programme with an adapted format mindful of the current context.
To view the preliminary programme topics, speakers, and session chairs, please click on the relevant links below.
Preliminary programme
Click on the session below to view the session topics.
- The Power of social connection in preventionChair: Prof. Geert Dom, BelgiumSpeaker: Prof. Julianne Holt-Lunstad, United States
- Mental health and war: impact on displaced peopleChair: Prof. Peter Falkai, GermanySpeaker: Prof. Unnur Anna Valdimarsdottir, Iceland
- Non-suicidal self injuryChair: Prof. Philip Gorwood, FranceSpeaker: Prof. Sabine Herpertz, Germany
- New treatments for dementiasChair: Dr. Cécile Hanon, FranceSpeaker: Prof. Peter Paul de Deyn, Belgium/Netherlands
- Innovative rehabilitation for adults with complex psychosisChair: Prof. Geert Dom, BelgiumSpeaker: Prof. Helen Killaspy, United Kingdom
- Gambling disorder and other behavioral addictions: recognition and treatmentChair: Prof. Geert Dom, BelgiumSpeaker: Prof. Anneke Goudriaan, Netherlands
- Trauma, stress and brain: the impact of war on mental healthChair: Prof. Martina Rojnić Kuzman, CroatiaSpeaker: Prof. Andreas Maercker, Switzerland
- Digital psychiatry: dream or reality?Chair: Prof. Umberto Volpe, ItalySpeaker: Prof. Heleen Riper, Netherlands
- Cost-effectiveness of psychotherapies and pharmacotherapies for mental disordersChair: Prof. Philip Gorwood, FranceSpeaker: Prof. Paul McCrone, United Kingdom
- Microdosing psychedelics – does that work?Chair: Prof. Simavi Vahip, Türkiye
Pro
Speaker: Dr. David Erritzoe, United KingdomCon
Speaker: Prof. Kim Kuypers, Netherlands - We need to abandon the current schizophrenia constructChair: Prof. Lars Lien, Norway
Pro
Speaker: Prof. Silvana Galderisi, ItalyCon
Speaker: Prof. Wolfgang Gaebel, Germany - Can psychiatry dispense with involuntary medication?Chair: Dr. Julian Beezhold, United Kingdom
Pro
Speaker: Prof. Istvan Bitter, HungaryCon
Speaker: Prof. Meryam Schouler-Ocak, Germany
- Proactive psychiatry: prevention of substance use and mental health problems – the potential of early (school-based) targeted prevention
Chair: Prof. Judit Balazs, HungaryCo-Chair: Prof. Geert Dom, BelgiumBuilding resilience by equipping teens with cognitive behavioural strategies to manage personality and individual differencesSpeaker: Prof. Patricia Conrod, CanadaProactive psychiatry of addiction: toward the normalization of early preventionSpeaker: Prof. Vincent Hendriks, NetherlandsSchool-based public mental health opportunitiesSpeaker: Dr. Jonathan Campion, United KingdomBullying prevention as a preventive strategy for mental healthSpeaker: Dr. Covadonga M Diaz-Canej, Spain
- Medical prospects of cannabis products, cannabinoids, in psychiatry and addiction medicine
Chair: Prof. Andrea Fiorillo, ItalyCo-Chair: Prof. Agata Szulc, PolandCannabis and cannabinoids for mental health indications: evidence of effect and adverse eventsSpeaker: Prof. Jørgen Bramness, NorwayEvidence-based prospects of cannabis derivatives in cannabis or alcohol addictionSpeaker: Prof. Benjamin Rolland, FrancePrescription of cannabinoids in psychiatry: (how) do we cross that door?Speaker: Dr. Albert Batalla Cases, NetherlandsCannabis in Sports: Good idea or not?Speaker: Dr. Eva Hoch, Germany
- Shared decision making in psychiatry: needs, evidence, barriers and opportunities
Chair: Prof. Michaela Amering, AustriaCo-Chair: Prof. Peter Falkai, GermanyShared decision making in patients with severe mental disordersSpeaker: Prof. Johannes Hamann, GermanyShared decision making in children, adolescents, including their parents or carersSpeaker: Prof. Hanna Christiansen, GermanyBarriers to overcome and opportunities to foster in shared decision making: attitudes and dilemmas of service users and providersSpeaker: Prof. Shulamit Ramon, United KingdomDigital opportunities for shared decision making in psychiatry: supportive interventionsSpeaker: Prof. Ulrich Reininghaus, United Kingdom
- Academic psychiatry: is gender equality within reach?
Chair: Prof. Michaela Amering, AustriaCo-Chair: Prof. Meryam Schouler-Ocak, GermanyHigh impact psychiatric publishing – gender parity within reach?Speaker: Prof. Andrea Gmeiner, AustriaHow to fix the leaky pipelineSpeaker: Prof. Sophia Frangou, USAMentoring for improving gender equality in academic psychiatrySpeaker: Prof. Anita Riecher-Rössler, SwitzerlandThe role of Journal editors towards closing the gender gapSpeaker: Dr. Joan Marsh, United Kingdom- The interplay between stress, inflammation and metabolism in major depression
Chair: Prof. Jerzy Samochowiec, PolandCo-Chair: Dr. Livia De Picker, BelgiumWhat does the immunometabolic status tell us about depression?Speaker: Prof. Pilar López García, SpainInflammation-induced depression: what does it really mean?Speaker: Prof. Carmine M Pariante, United KingdomImmunometabolic stress in depression: Who is affected, and how to treat?Speaker: Prof. Brenda Penninx, NetherlandsClinical correlates of stress, immune and metabolic markers in major depressionSpeaker: Dr. Virginia Soria, Spain- The assessment of therapeutic interventions using Proms and Prems
Chair: Prof. Philip Gorwood, FranceCo-Chair: Prof. Inez Myin-Germeys, BelgiumESM as a window in a person’s real lifeSpeaker: Prof. Inez Myin-Germeys, BelgiumImproving the effectiveness of mental health care through the use of PROMs and PREMs; the OECD perspectiveSpeaker: Dr. Katherine de Bienassis, FranceSocial inclusion: a fundamental PROM for evaluating recovery-oriented global mental health programmesSpeaker: Prof. Bernd Puschner, GermanyPersonal recovery, clinical recovery and patient-rated measuresSpeaker: Prof. Mike Slade, United Kingdom - Academic psychiatry: is gender equality within reach?
Ask the Experts
Ask the Experts sessions allow participants to meet in a small group with outstanding researchers and clinicians. The format is designed to facilitate informal discussions, allowing participants to present their questions and gain new perspectives. Sessions take place at round tables and are limited to 7 participants with advanced sign-up required. Sessions last 90 minutes with 5 experts per session and two groups of participants (45 minutes for each group).
Registration for the sessions will take place directly at the registration desk on-site.
Please note, the sessions will take place within the Exhibition area in the Hall Passy B.
ASK THE EXPERTS 1
Sunday 26 March
(10:00-11:30)
- Use of psychedelic drugs in clinical psychiatry
Dr. Michael Bogenschutz – USA - Complex post-traumatic stress disorder
Dr. Andreas Maercker – Switzerland - Non-pharmacological treatments for dementia
Prof. Peter Paul de Deyn – Belgium/Netherlands - How to assess early psychoses
Prof. Andrea Raballo – Italy - Early intervention in psychosis- past, present and future
Prof. Nandini Chakraborty – UK
ASK THE EXPERTS 2
Monday 27 March
(10:00-11:30)
- Ethical issues in clinical practice
Prof. Silvana Galderisi – Italy - How to implement preventive strategies in clinical settings
Prof. Julianne Holt-Lunstad – USA - From evidence to implementation or digital mental health in routine care, do’s and don’ts
Prof. Heleen Riper – Netherlands
ASK THE EXPERTS 3
Tuesday 28 March
(10:00-11:30)
- Supporting recovery from and with severe mental illness
Prof. Mike Slade – United Kingdom - Reslience among adolescents and young persons
Prof. Patricia Conrod – Canada - Addiction and psychiatric comorbidity in young people: treatment considerations
Prof. Vincent Hendriks -Netherlands - Costs and drawbacks of ESM in clinical practice
Prof. Inez Myin-Germeys – Belgium - How to evaluate costs of psychotherapy
Prof. Paul McCrone – United Kingdom
Session descriptions
The EPA 2023 scientific programme will cover the latest developments in psychiatry, through state-of-art presentations, live moderation, discussions, and more.
EPA Courses
State-of-the-Art Sessions
Plenary Sessions
Pro & Con Debates
Symposia Sessions
Workshops
Early Career Psychiatrists Programme
Ask the Expert Sessions
EPA Forum
Sponsored Sessions
Thank you for submitting your research
Late-breaking abstract submissions closed on 25 November 2022
Authors were invited to submit abstracts, classified by topics. There is a limitation concerning the number of submissions per individual. Submitted abstracts are being reviewed by the Scientific Programme Committee and scheduled as Oral Communications Sessions, e-Poster Presentations, or e-Poster Viewing.
Oral Communications Sessions
Those abstracts scoring the highest will be allotted an Oral Communication session. The author will have the opportunity to present their research in a dedicated session during the Congress.
All accepted abstracts whose authors attended the Congress are published in the European Psychiatry Digital Abstract Supplement during and following the Congress.
e-Poster Presentations
Authors of abstracts allotted to the second-highest category of scoring are invited to present their research findings or important ongoing research during an e-Poster Presentation, where they have around 3 minutes to present their e-Posters displayed on a digital screen.
All accepted abstracts whose authors attended the Congress are published in the European Psychiatry Digital Abstract Supplement during and following the Congress.
e-Poster Viewing
All authors of accepted abstracts will be able to view their poster on the congress website, app and on the digital screens onsite. The e-Posters are accessible to all delegates throughout the Congress for individual viewing.
All accepted abstracts whose authors attended the Congress are published in the European Psychiatry Digital Abstract Supplement during and following the Congress.